Evvy, the precision women’s health company, today announced the launch of the Evvy UTI+ Test, a comprehensive at-home urine ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Basel: Roche has announced the CE Mark for its cobas BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately ...
Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly ...
1d
Co-Diagnostics to Present on Co-Dx(TM) PCR Platform and AI Integration at Point-of-Care Testing 2025
*The Co-Dx PCR platform (including the Co-Dx PCR Home (TM), Co-Dx PCR Pro (TM), mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is ...
Evvy’s new UTI+ Test and microbiome tools deliver faster, clearer insights into BV and UTI care, reshaping women’s health ...
Roche introduces new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark: Basel Wednesday, December 10, 2025, 15:00 Hrs ...
Termite pellets can linger long after the insects that dropped them have disappeared. By testing for microbes in the ...
The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...
Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...
Basel: Roche has announced that its first point-of-care test for the diagnosis of whooping cough (pertussis) and other ...
The test helps diagnose infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback